Ligand Pharmaceuticals | LGND - Ebit

Stock Price
196.95
Daily Change
-1.89 -0.95%
Monthly
2.56%
Yearly
67.89%
Q1 Forecast
186.18

Ligand Pharmaceuticals reported $158.89M in EBIT for its fiscal quarter ending in September of 2025.





Ebit Change Date
Amgen USD 3.96B 464M Dec/2025
Arrowhead Research USD 57.82M 223.36M Sep/2025
Baxter International USD 201.2M 70.8M Sep/2025
Bristol-Myers Squibb USD 4.04B 1.78B Sep/2025
Eli Lilly USD 7.41B 391.2M Sep/2025
Gilead Sciences USD 3.51B 810M Sep/2025
GlaxoSmithKline GBP 2.79B 716M Sep/2025
Glaxosmithkline GBP 3.76B 1.69B Sep/2025
Insmed USD -261.35M 7.48M Sep/2025
Ionis Pharmaceuticals USD -160.18M 304.96M Sep/2025
Ligand Pharmaceuticals USD 158.89M 115.32M Sep/2025
MacroGenics USD 20.16M 55.51M Sep/2025
Merck USD 6.24B 1.32B Dec/2025
Pacira USD 13.15M 2.92M Sep/2025
Pfizer USD 4.65B 71M Dec/2025
Veracyte USD 23.11M 8.8M Sep/2025